Mini Cart
Loading cart...
GLP2-T
$79.00 – $550.00
In Stock
BW2-T (Tirzepatide)
Available Vial Sizes: 5 mg, 10 mg, 20 mg, 30 mg , 40 mg, 60 mg and 120 mg in a 3 mL vial
Tirzepatide is a novel synthetic dual agonist peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is widely studied for its potent effects on metabolic regulation, glucose homeostasis, appetite suppression, and body weight management in laboratory and preclinical models.
In research settings, tirzepatide has shown superior efficacy compared to single GLP-1 agonists by simultaneously enhancing insulin secretion (glucose-dependent), suppressing glucagon release, slowing gastric emptying, and significantly reducing food intake. These combined actions make it a powerful research tool for investigating obesity, type 2 diabetes, cardiovascular outcomes, and advanced metabolic disorders.
This compound is offered strictly for research use only (RUO)
Dosage
No description available.
Additional information
| Dosage | 5mg, 10mg, 20mg, 40mg, 30mg, 60mg, 120mg |
|---|
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Blue Wave Compounds is a chemical supplier. Blue Wave Compounds is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Blue Wave Compounds is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.